GLP-1 agonists , or glucagon-like peptide-1 compounds , are representing as a substantial development in addressing diabetes mellitus . These innovative therapies work by increasing insulin production and https://glp1177171.blognody.com/51431127/glp-1-a-promising-approach-in-glucose-management